Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMIND: Dotarem vs Gadovist for Brain Tumor MRI
NCT02034708Phase 4Completed
- Sponsor
- Guerbet
- Start
- Jun 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of gadoterate meglumine in brain tumor, sponsored by Guerbet. Started Jun 2014; status: completed.
02
Drugs
gadoterate meglumine
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT02034708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034708.